NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a commercial-stage biopharmaceutical company that develops and markets biosurgical and antibody-based products, announced today that Michael Burshtine, Senior Vice President and Chief Financial Officer, is scheduled to give a company presentation at the C.E. Unterberg, Towbin Emerging Growth Healthcare Conference on Monday, October 30, 2006 at 9:00 am ET at The Palace Hotel in New York City.
